Saxenda may not be safe for everyone
Following such guidance risks serious harm, including incorrect dosing, microbial contamination, and unpredictable adverse effects
Currently, Wegovy is FDA approved for the following: Children ages 12 years or older with a body mass index (BMI) at or above the 95th percentile for their sex and age Adults with a BMI at or above 30 Adults with a BMI at or above 27 and at least one weight-related health condition, such as heart disease, diabetes, high blood pressure, or sleep apnea Adults with a BMI at or above 27 with established cardiovascular disease and a risk of major adverse cardiovascular events (like heart attack or stroke) Adults with noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with moderate to advanced liver fibrosis Note that there are slightly different prescribing rules for Wegovy pills versus Wegovy injections
Toxicological studies have delved into the hemolytic activity of BV in various species, such as horses, humans, sheep, and rabbits, shedding light on its cytotoxic effects
Tracking is provided for every shipment, and shipments are insured for lost packages (except when incorrect shipping information was provided)